Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 35.43 CNY 1.23% Market Closed
Market Cap: 32.3B CNY

Intrinsic Value

The intrinsic value of one Livzon Pharmaceutical Group Inc stock under the Base Case scenario is 43.6 CNY. Compared to the current market price of 35.43 CNY, Livzon Pharmaceutical Group Inc is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
43.6 CNY
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Livzon Pharmaceutical Group Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Livzon Pharmaceutical Group Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Livzon Pharmaceutical Group Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Livzon Pharmaceutical Group Inc
SZSE:000513
CN
Pharmaceuticals
Market Cap
32.8B CNY
IPO
Oct 28, 1993
CN
Pharmaceuticals
Market Cap
32.8B CNY
IPO
Oct 28, 1993
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Livzon Pharmaceutical Group Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Livzon Pharmaceutical Group Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Livzon Pharmaceutical Group Inc

Current Assets 16.6B
Cash & Short-Term Investments 10.8B
Receivables 3.5B
Other Current Assets 2.3B
Non-Current Assets 8.3B
Long-Term Investments 1.7B
PP&E 4.6B
Intangibles 841.2m
Other Non-Current Assets 1.2B
Efficiency

Free Cash Flow Analysis
Livzon Pharmaceutical Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Livzon Pharmaceutical Group Inc

Revenue
11.9B CNY
Cost of Revenue
-4.2B CNY
Gross Profit
7.6B CNY
Operating Expenses
-5B CNY
Operating Income
2.6B CNY
Other Expenses
-561m CNY
Net Income
2B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
59/100
Profitability
Score

Livzon Pharmaceutical Group Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Livzon Pharmaceutical Group Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
High Altman Z-Score
Long-Term Solvency
69/100
Solvency
Score

Livzon Pharmaceutical Group Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Livzon Pharmaceutical Group Inc

Wall Street analysts forecast Livzon Pharmaceutical Group Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Livzon Pharmaceutical Group Inc is 38.79 CNY with a low forecast of 30.66 CNY and a high forecast of 47.04 CNY.

Lowest
Price Target
30.66 CNY
13% Downside
Average
Price Target
38.79 CNY
9% Upside
Highest
Price Target
47.04 CNY
33% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Livzon Pharmaceutical Group Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Livzon Pharmaceutical Group Inc stock?

The intrinsic value of one Livzon Pharmaceutical Group Inc stock under the Base Case scenario is 43.6 CNY.

Is Livzon Pharmaceutical Group Inc stock undervalued or overvalued?

Compared to the current market price of 35.43 CNY, Livzon Pharmaceutical Group Inc is Undervalued by 19%.

Back to Top